NICE guidelines for diabetes mellitus, type 2
Clinical QuestionWhat does the National Institute of Clinical Effectiveness (NICE) recommend regarding the treatment of patients with type 2 diabetes?
Bottom LineThe British NICE guidelines suggest good blood pressure control, metformin as initial treatment, daily aspirin, and statin treatment for most patients with type 2 diabetes (regardless of initial cholesterol level). These guidelines differ from the American Diabetes Association guidelines in that they are much more patient-centered and much less aggressive in their pursuit of sustained lower glucose levels. (LOE = 5)
ReferenceHome P, Mant J, Diaz J, Turner C, on behalf of the Guideline Development Group. Management of type 2 diabetes: updated NICE guidance. BMJ 2008;336:1306-8. [PMID:3081394]
Study DesignPractice guideline
SynopsisThe NICE guidelines are derived from systematic reviews, supplemented, when minimal evidence is available, with recommendations based on expert opinion. Moving toward a more patient-centered approach that has not caught on the U.S., the organization recommends involving patients in setting targets for their individual A1c levels, blood pressure, and lipid levels. Based on moderate evidence and expert opinion, the recommend structured education based on the needs of the individual, delivered by trained educatiors. Nutrition advice should be offered as well. They suggest home (self) glucose monitoring only as an aid to education, with continual reassessment of its need for an individual. Other recommendations: 1) Blood pressure control should be addressed in patients with a confirmed blood pressure of >140/80 mmHg or >130/80 mm Hg with organ changes (high to moderate evidence). 2) Metformin should be first line treatment in most patients, following a trial of lifestyle changes and education (high quality evidence) 3) All patients with diabetes over the age of 50 years should receive daily aspirin, and younger patients with risk for cardiovascular disease (Moderate quality evidence) 4) Start statin treatment in most people at least 40 years old and in younger people with cardiovascular risk. Increase the dose to maintain a cholesterol less than 155 mg/dl (4.0 mmol/l) or low density lipoprotein <77 mg/dl (2.0 mmol/l). Based on high quality evidence. 5) Monitor albumin secretion, visual acuity, and neuropathic symptoms (expert opinion to high quality evidence)
Barry, Henry, et al., editors. "NICE Guidelines for Diabetes Mellitus, Type 2." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/426502/all/NICE_guidelines_for_diabetes_mellitus__type_2.
NICE guidelines for diabetes mellitus, type 2. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426502/all/NICE_guidelines_for_diabetes_mellitus__type_2. Accessed May 29, 2023.
NICE guidelines for diabetes mellitus, type 2. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426502/all/NICE_guidelines_for_diabetes_mellitus__type_2
NICE Guidelines for Diabetes Mellitus, Type 2 [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 May 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426502/all/NICE_guidelines_for_diabetes_mellitus__type_2.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - NICE guidelines for diabetes mellitus, type 2 ID - 426502 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426502/all/NICE_guidelines_for_diabetes_mellitus__type_2 PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -